文献速递心脑血管急症重症综合管理与镇静镇痛

治疗心脏骤停后昏迷幸存者的节律性和周期性脑电图模式

Treating Rhythmic and Periodic EEG Patterns in Comatose Survivors of Cardiac Arrest.
PubMed 文献 · N Engl J Med · 2022-01-01
一句话结论心脏骤停后昏迷患者中,用抗癫痫药物抑制节律性和周期性脑电图活动至少48小时并未改善3个月神经预后。

这项开放标签试验将172例心脏骤停后昏迷幸存者随机分为抗癫痫药物逐步抑制节律性和周期性脑电图活动至少连续48小时加标准治疗组(88例)或单纯标准治疗组(84例),两组均接受目标温度管理。节律性或周期性脑电图活动在心脏骤停后中位35小时被检出,157例有数据者中98例(62%)存在肌阵挛。抗癫痫治疗组49/88例(56%)实现连续48小时完全抑制,对照组2/83例(2%)。3个月时抗癫痫治疗组79/88例(90%)和对照组77/84例(92%)神经预后不良(差异2个百分点,95%CI -7至11,P=0.68),两组死亡率分别为80%和82%,抗癫痫治疗组ICU住院时间和机械通气时间略长。

要点

  • 心脏骤停后昏迷患者中,节律性和周期性脑电图活动在心脏骤停后中位35小时被检出,157例有数据者中98例(62%)存在肌阵挛。
  • 抗癫痫药物逐步抑制节律性和周期性脑电图活动至少连续48小时,仅49/88例(56%)实现完全抑制,对照组为2/83例(2%)。
  • 3个月神经预后不良率抗癫痫治疗组90%(79/88)vs 对照组92%(77/84),差异2个百分点(95%CI -7至11,P=0.68),未达统计学显著。
  • 3个月死亡率抗癫痫治疗组80% vs 对照组82%,抗癫痫治疗组ICU住院时间和机械通气时间略长。

适用人群与场景

  • 心脏骤停后昏迷幸存者,连续脑电图监测检出节律性和周期性脑电图模式。
  • 两组均接受目标温度管理作为标准治疗的一部分。

诊断标准与关键阈值

  • 连续脑电图监测检出节律性和周期性脑电图模式。
  • 主要结局为3个月时根据脑功能表现分类(CPC)评分判定的神经预后,二分为良好预后(CPC评分指示无、轻度或中度残疾)或不良预后(CPC评分指示重度残疾、昏迷或死亡)。

处置流程与药物剂量

  • 抗癫痫治疗组采用逐步抗癫痫药物策略,抑制节律性和周期性脑电图活动至少连续48小时,加标准治疗。
  • 对照组仅接受标准治疗,两组标准治疗均包括目标温度管理。

研究设计与关键结果

  • 开放标签试验纳入172例,抗癫痫治疗组88例,对照组84例。
  • 节律性或周期性脑电图活动在心脏骤停后中位35小时被检出;157例有数据者中98例(62%)存在肌阵挛。
  • 连续48小时完全抑制节律性和周期性脑电图活动:抗癫痫治疗组49/88例(56%)vs 对照组2/83例(2%)。
  • 3个月神经预后不良:抗癫痫治疗组79/88例(90%)vs 对照组77/84例(92%),差异2个百分点(95%CI -7至11,P=0.68)。
  • 3个月死亡率:抗癫痫治疗组80% vs 对照组82%。
  • 抗癫痫治疗组平均ICU住院时间和平均机械通气时间较对照组略长。

证据类型、等级与局限

  • 证据类型:开放标签随机对照试验。
  • 资金:荷兰癫痫基金会;TELSTAR,ClinicalTrials.gov注册号NCT02056236。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在心脏骤停后昏迷幸存者中,用抗癫痫药物抑制节律性和周期性脑电图活动至少48小时加标准治疗,与单纯标准治疗相比,3个月神经预后不良发生率无显著差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Whether the treatment of rhythmic and periodic electroencephalographic (EEG) patterns in comatose survivors of cardiac arrest improves outcomes is uncertain.

METHODS: We conducted an open-label trial of suppressing rhythmic and periodic EEG patterns detected on continuous EEG monitoring in comatose survivors of cardiac arrest. Patients were randomly assigned in a 1:1 ratio to a stepwise strategy of antiseizure medications to suppress this activity for at least 48 consecutive hours plus standard care (antiseizure-treatment group) or to standard care alone (control group); standard care included targeted temperature management in both groups. The primary outcome was neurologic outcome according to the score on the Cerebral Performance Category (CPC) scale at 3 months, dichotomized as a good outcome (CPC score indicating no, mild, or moderate disability) or a poor outcome (CPC score indicating severe disability, coma, or death). Secondary outcomes were mortality, length of stay in the intensive care unit (ICU), and duration of mechanical ventilation.

RESULTS: We enrolled 172 patients, with 88 assigned to the antiseizure-treatment group and 84 to the control group. Rhythmic or periodic EEG activity was detected a median of 35 hours after cardiac arrest; 98 of 157 patients (62%) with available data had myoclonus. Complete suppression of rhythmic and periodic EEG activity for 48 consecutive hours occurred in 49 of 88 patients (56%) in the antiseizure-treatment group and in 2 of 83 patients (2%) in the control group. At 3 months, 79 of 88 patients (90%) in the antiseizure-treatment group and 77 of 84 patients (92%) in the control group had a poor outcome (difference, 2 percentage points; 95% confidence interval, -7 to 11; P = 0.68). Mortality at 3 months was 80% in the antiseizure-treatment group and 82% in the control group. The mean length of stay in the ICU and mean duration of mechanical ventilation were slightly longer in the antiseizure-treatment group than in the control group.

CONCLUSIONS: In comatose survivors of cardiac arrest, the incidence of a poor neurologic outcome at 3 months did not differ significantly between a strategy of suppressing rhythmic and periodic EEG activity with the use of antiseizure medication for at least 48 hours plus standard care and standard care alone. (Funded by the Dutch Epilepsy Foundation; TELSTAR ClinicalTrials.gov number, NCT02056236.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Ruijter BJ, Keijzer HM, Tjepkema-Cloostermans MC, et al. Treating Rhythmic and Periodic EEG Patterns in Comatose Survivors of Cardiac Arrest. N Engl J Med. 2022. PMID: 35196426. doi:10.1056/NEJMoa2115998

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。